{"type":"kani_spawn","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","depth":0,"parent":null,"children":[],"always_included_messages":[],"chat_history":[],"state":"stopped","name":"kanpai","engine_type":"OpenAIEngine","functions":[{"name":"search","desc":"Search Wikipedia for an article with the given title, and get its content. If no such article is found, return similar article names.","auto_retry":true,"auto_truncate":null,"after":"assistant","json_schema":{"properties":{"query":{"type":"string"}},"required":["query"],"type":"object"}}]}
{"type":"kani_state_change","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","state":"running"}
{"type":"kani_message","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","msg":{"role":"user","content":"What are the symptoms of the top 5 mortality cancers in the world amongst females?","name":null,"tool_call_id":null,"tool_calls":null,"is_tool_call_error":null}}
{"type":"root_message","msg":{"role":"user","content":"What are the symptoms of the top 5 mortality cancers in the world amongst females?","name":null,"tool_call_id":null,"tool_calls":null,"is_tool_call_error":null}}
{"type":"kani_message","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","msg":{"role":"assistant","content":null,"name":null,"tool_call_id":null,"tool_calls":[{"id":"call_V5qEQfJTEqlDju3yQd9LGjTx","type":"function","function":{"name":"search","arguments":"{\"query\": \"Breast cancer\"}"}},{"id":"call_o0VEXA8LDvE3bzVDW34YWIzd","type":"function","function":{"name":"search","arguments":"{\"query\": \"Lung cancer\"}"}},{"id":"call_Nt6crxtybqLnYF5GFQMKVZC4","type":"function","function":{"name":"search","arguments":"{\"query\": \"Colorectal cancer\"}"}},{"id":"call_UjaSW8C5KZwdJYcOCW0gReqs","type":"function","function":{"name":"search","arguments":"{\"query\": \"Cervical cancer\"}"}},{"id":"call_RX0JlYpuntex7seC1lL3SoLN","type":"function","function":{"name":"search","arguments":"{\"query\": \"Stomach cancer\"}"}}],"is_tool_call_error":null}}
{"type":"root_message","msg":{"role":"assistant","content":null,"name":null,"tool_call_id":null,"tool_calls":[{"id":"call_V5qEQfJTEqlDju3yQd9LGjTx","type":"function","function":{"name":"search","arguments":"{\"query\": \"Breast cancer\"}"}},{"id":"call_o0VEXA8LDvE3bzVDW34YWIzd","type":"function","function":{"name":"search","arguments":"{\"query\": \"Lung cancer\"}"}},{"id":"call_Nt6crxtybqLnYF5GFQMKVZC4","type":"function","function":{"name":"search","arguments":"{\"query\": \"Colorectal cancer\"}"}},{"id":"call_UjaSW8C5KZwdJYcOCW0gReqs","type":"function","function":{"name":"search","arguments":"{\"query\": \"Cervical cancer\"}"}},{"id":"call_RX0JlYpuntex7seC1lL3SoLN","type":"function","function":{"name":"search","arguments":"{\"query\": \"Stomach cancer\"}"}}],"is_tool_call_error":null}}
{"type":"tokens_used","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","prompt_tokens":80,"completion_tokens":98}
{"type":"foqa_article_retrieved","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","article_title":"Colorectal cancer","article_pageid":206979,"article_revid":1185068172}
{"type":"foqa_article_retrieved","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","article_title":"Stomach cancer","article_pageid":261613,"article_revid":1184149908}
{"type":"foqa_retrieval_type","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","retrieved_tokens":1281,"max_search_tokens":1365,"retrieval_type":"openai"}
{"type":"foqa_article_retrieved","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","article_title":"Lung cancer","article_pageid":18450,"article_revid":1182616742}
{"type":"foqa_retrieval_type","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","retrieved_tokens":1335,"max_search_tokens":1365,"retrieval_type":"openai"}
{"type":"foqa_article_retrieved","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","article_title":"Cervical cancer","article_pageid":53338,"article_revid":1185523565}
{"type":"foqa_retrieval_type","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","retrieved_tokens":1266,"max_search_tokens":1365,"retrieval_type":"openai"}
{"type":"foqa_article_retrieved","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","article_title":"Breast cancer","article_pageid":70547,"article_revid":1185527758}
{"type":"foqa_retrieval_type","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","retrieved_tokens":1095,"max_search_tokens":1365,"retrieval_type":"openai"}
{"type":"foqa_retrieval_type","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","retrieved_tokens":1290,"max_search_tokens":1365,"retrieval_type":"openai"}
{"type":"kani_message","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","msg":{"role":"function","content":"<document>\n<title>Breast cancer</title>\n<fragment>\nWorldwide, breast cancer is the most-common invasive cancer in women.[199] Along with lung cancer, breast cancer is the most commonly diagnosed cancer, with 2.09 million cases each in 2018.[200] Breast cancer affects 1 in 7 (14%) of women worldwide.[201] (The most common form of cancer is non-invasive non-melanoma skin cancer; non-invasive cancers are generally easily cured, cause very few deaths, and are routinely excluded from cancer statistics.) Breast cancer comprises 22.9% of invasive cancers in women[202] and 16% of all female cancers.[203] In 2012, it comprised 25.2% of cancers diagnosed in women, making it the most-common female cancer.[204]\n\n\nIn 2008, breast cancer caused 458,503 deaths worldwide (13.7% of cancer deaths in women and 6.0% of all cancer deaths for men and women together).[202] Lung cancer, the second most-common cause of cancer-related deaths in women, caused 12.8% of cancer deaths in women (18.2% of all cancer deaths for men and women together).[202]\n\n\n</fragment>\n<fragment>\nIn 2002 it was noted that as a result of breast cancer's high visibility, the statistical results can be misinterpreted, such as the claim that one in eight women will be diagnosed with breast cancer during their lives – a claim that depends on the unrealistic assumption that no woman will die of any other disease before the age of 95.[220]: 199–200 By 2010 the breast cancer survival rate in Europe was 91% at one years and 65% at five years. In the USA the five-year survival rate for localized breast cancer was 96.8%, while in cases of metastases it was only 20.6%. Because the prognosis for breast cancer was at this stage relatively favorable, compared to the prognosis for other cancers, breast cancer as cause of death among women was 13.9% of all cancer deaths. The second most common cause of death from cancer in women was lung cancer, the most common cancer worldwide for men and women. The improved survival rate made breast cancer the most prevalent cancer in the world. \n</fragment>\n<fragment>\nand targeted therapy.[1] Types of surgery vary from breast-conserving surgery to mastectomy.[13][14] Breast reconstruction may take place at the time of surgery or at a later date.[14] In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.[14]\n\n\nOutcomes for breast cancer vary depending on the cancer type, the extent of disease, and the person's age.[14] The five-year survival rates in England and the United States are between 80 and 90%.[15][4][5] In developing countries, five-year survival rates are lower.[2] Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases.[16] In 2018, it resulted in 2 million new cases and 627,000 deaths.[17] It is more common in developed countries[2] and is more than 100 times more common in women than in men.[15][18]\n\n\n\n\n## Signs and symptoms[edit]\n\n\n</fragment>\n<fragment>\n6. ^ ***a*** ***b*** Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (May 2021). \"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries\". *CA: A Cancer Journal for Clinicians*. **71** (3): 209–249. doi:10.3322/caac.21660. PMID 33538338. S2CID 231804598.\n7. **^** \"Breast Cancer\". *NCI*. January 1980. Archived from the original on 25 June 2014. Retrieved 29 June 2014.\n8. **^** Saunders C, Jassal S (2009). *Breast cancer* (1. ed.). Oxford: Oxford University Press. p. Chapter 13. ISBN 978-0-19-955869-8. Archived from the original on 25 October 2015.\n9. **^** Fakhri N, Chad MA, Lahkim M, Houari A, Dehbi H, Belmouden A, El Kadmiri N (September 2022). \"Risk factors for breast cancer in women: an update review\". *Medical Oncology*. **39** (12): 197. doi:10.1007/s12032-022-01804-x. PMID 36071255. S2CID 252113509.\n\n</fragment>\n<fragment>\n\n| Breast cancer |\n| --- |\n| ![As seen on the image above the breast is already affected with cancer](image) |\n| An illustration of breast cancer |\n| Specialty | Oncology |\n| Symptoms | A lump in a breast, a change in breast shape, dimpling of the skin, fluid from the nipple, a newly inverted nipple, a red scaly patch of skin on the breast[1] |\n| Risk factors | Being female, obesity, lack of exercise, alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late in life or not at all, older age, prior breast cancer, family history of breast cancer, Klinefelter syndrome[1][2][3] |\n| Diagnostic method | Tissue biopsy[1] Mammography |\n| Treatment | Surgery, radiation therapy, chemotherapy, hormonal therapy, targeted therapy[1] |\n| Prognosis | Five-year survival rate ≈85% (US, UK)[4][5] |\n| Frequency | 2.2 million affected (global, 2020)[6] |\n| Deaths | 685,000 (global, 2020)[6] |\n\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_V5qEQfJTEqlDju3yQd9LGjTx","tool_calls":null,"is_tool_call_error":false}}
{"type":"root_message","msg":{"role":"function","content":"<document>\n<title>Breast cancer</title>\n<fragment>\nWorldwide, breast cancer is the most-common invasive cancer in women.[199] Along with lung cancer, breast cancer is the most commonly diagnosed cancer, with 2.09 million cases each in 2018.[200] Breast cancer affects 1 in 7 (14%) of women worldwide.[201] (The most common form of cancer is non-invasive non-melanoma skin cancer; non-invasive cancers are generally easily cured, cause very few deaths, and are routinely excluded from cancer statistics.) Breast cancer comprises 22.9% of invasive cancers in women[202] and 16% of all female cancers.[203] In 2012, it comprised 25.2% of cancers diagnosed in women, making it the most-common female cancer.[204]\n\n\nIn 2008, breast cancer caused 458,503 deaths worldwide (13.7% of cancer deaths in women and 6.0% of all cancer deaths for men and women together).[202] Lung cancer, the second most-common cause of cancer-related deaths in women, caused 12.8% of cancer deaths in women (18.2% of all cancer deaths for men and women together).[202]\n\n\n</fragment>\n<fragment>\nIn 2002 it was noted that as a result of breast cancer's high visibility, the statistical results can be misinterpreted, such as the claim that one in eight women will be diagnosed with breast cancer during their lives – a claim that depends on the unrealistic assumption that no woman will die of any other disease before the age of 95.[220]: 199–200 By 2010 the breast cancer survival rate in Europe was 91% at one years and 65% at five years. In the USA the five-year survival rate for localized breast cancer was 96.8%, while in cases of metastases it was only 20.6%. Because the prognosis for breast cancer was at this stage relatively favorable, compared to the prognosis for other cancers, breast cancer as cause of death among women was 13.9% of all cancer deaths. The second most common cause of death from cancer in women was lung cancer, the most common cancer worldwide for men and women. The improved survival rate made breast cancer the most prevalent cancer in the world. \n</fragment>\n<fragment>\nand targeted therapy.[1] Types of surgery vary from breast-conserving surgery to mastectomy.[13][14] Breast reconstruction may take place at the time of surgery or at a later date.[14] In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.[14]\n\n\nOutcomes for breast cancer vary depending on the cancer type, the extent of disease, and the person's age.[14] The five-year survival rates in England and the United States are between 80 and 90%.[15][4][5] In developing countries, five-year survival rates are lower.[2] Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases.[16] In 2018, it resulted in 2 million new cases and 627,000 deaths.[17] It is more common in developed countries[2] and is more than 100 times more common in women than in men.[15][18]\n\n\n\n\n## Signs and symptoms[edit]\n\n\n</fragment>\n<fragment>\n6. ^ ***a*** ***b*** Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (May 2021). \"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries\". *CA: A Cancer Journal for Clinicians*. **71** (3): 209–249. doi:10.3322/caac.21660. PMID 33538338. S2CID 231804598.\n7. **^** \"Breast Cancer\". *NCI*. January 1980. Archived from the original on 25 June 2014. Retrieved 29 June 2014.\n8. **^** Saunders C, Jassal S (2009). *Breast cancer* (1. ed.). Oxford: Oxford University Press. p. Chapter 13. ISBN 978-0-19-955869-8. Archived from the original on 25 October 2015.\n9. **^** Fakhri N, Chad MA, Lahkim M, Houari A, Dehbi H, Belmouden A, El Kadmiri N (September 2022). \"Risk factors for breast cancer in women: an update review\". *Medical Oncology*. **39** (12): 197. doi:10.1007/s12032-022-01804-x. PMID 36071255. S2CID 252113509.\n\n</fragment>\n<fragment>\n\n| Breast cancer |\n| --- |\n| ![As seen on the image above the breast is already affected with cancer](image) |\n| An illustration of breast cancer |\n| Specialty | Oncology |\n| Symptoms | A lump in a breast, a change in breast shape, dimpling of the skin, fluid from the nipple, a newly inverted nipple, a red scaly patch of skin on the breast[1] |\n| Risk factors | Being female, obesity, lack of exercise, alcohol, hormone replacement therapy during menopause, ionizing radiation, early age at first menstruation, having children late in life or not at all, older age, prior breast cancer, family history of breast cancer, Klinefelter syndrome[1][2][3] |\n| Diagnostic method | Tissue biopsy[1] Mammography |\n| Treatment | Surgery, radiation therapy, chemotherapy, hormonal therapy, targeted therapy[1] |\n| Prognosis | Five-year survival rate ≈85% (US, UK)[4][5] |\n| Frequency | 2.2 million affected (global, 2020)[6] |\n| Deaths | 685,000 (global, 2020)[6] |\n\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_V5qEQfJTEqlDju3yQd9LGjTx","tool_calls":null,"is_tool_call_error":false}}
{"type":"kani_message","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","msg":{"role":"function","content":"<document>\n<title>Lung cancer</title>\n<fragment>\nWorldwide, lung cancer is the most diagnosed type of cancer, and the leading cause of cancer death.[94][95] In 2020, 2.2 million new cases were diagnosed, and 1.8 million people died from lung cancer, representing 18% of all cancer deaths.[3] Lung cancer deaths are expected to rise globally to nearly 3 million annual deaths by 2035, due to high rates of tobacco use and aging populations.[95] Lung cancer is rare in those younger than 40; after that, cancer rates increase with age, stabilizing around age 80.[1] The median age of a person diagnosed with lung cancer is 70; the median age of death is 72.[2]\n\n\n</fragment>\n<fragment>\n\nAround 19% of people diagnosed with lung cancer survive five years from diagnosis, though prognosis varies based on the stage of the disease at diagnosis and the type of lung cancer.[4] Prognosis is better for people with lung cancer diagnosed at an earlier stage; those diagnosed at the earliest TNM stage, IA1 (small tumor, no spread), have a two-year survival of 97% and five-year survival of 92%.[57] Those diagnosed at the most-advanced stage, IVB, have a two-year survival of 10% and a five-year survival of 0%.[57] Five-year survival is higher in women (22%) than men (16%).[4] Women tend to be diagnosed with less-advanced disease, and have better outcomes than men diagnosed at the same stage.[58] Average five-year survival also varies across the world, with particularly high five-year survival in Japan (33%), and five-year survival above 20% in 12 other countries: Mauritius, Canada, the US, China, South Korea, Taiwan, Israel, Latvia, Iceland, Sweden, Austria, and Switzerland.[59]\n\n\n</fragment>\n<fragment>\n\nLung cancer is the most diagnosed and deadliest cancer worldwide, with 2.2 million cases in 2020 resulting in 1.8 million deaths.[3] Lung cancer is rare in those younger than 40; the average age at diagnosis is 70 years, and the average age at death 72.[2] Incidence and outcomes vary widely across the world, depending on patterns of tobacco use. Prior to the advent of cigarette smoking in the 20th century, lung cancer was a rare disease. In the 1950s and 1960s, increasing evidence linked lung cancer and tobacco use, culminating in declarations by most large national health bodies discouraging tobacco use.\n\n\n\n\n## Signs and symptoms[edit]\n\n\n</fragment>\n<fragment>\n\nLung cancer incidence varies by geography and sex, with the highest rates in Micronesia, Polynesia, Europe, Asia, and North America; and lowest rates in Africa and Central America.[96] Globally, around 8% of men and 6% of women develop lung cancer in their lifetimes.[1] The ratio of lung cancer cases in men to women varies considerably by geography, from as high as nearly 12:1 in Belarus, to 1:1 in Brazil, likely due to differences in smoking patterns.[97]\n\n\n</fragment>\n<fragment>\n57. ^ ***a*** ***b*** ***c*** Goldstraw et al. 2016, \"Figure 2\".\n58. ^ ***a*** ***b*** Rivera, Mody & Weiner 2022, \"Prognostic and Predictive Factors in Lung Cancer\".\n59. **^** Allemani et al. 2018, \"Lung\".\n60. ^ ***a*** ***b*** Temel, Petrillo & Greer 2022, \"Coping with Prognostic Uncertainty\".\n61. **^** \"What Causes Lung Cancer\". American Cancer Society. 1 October 2019. Retrieved 31 January 2023.\n62. **^** \"What Causes Lung Cancer?\". American Lung Association. 17 November 2022. Retrieved 31 January 2023.\n63. **^** Massion & Lehman 2022, Table 73.1: Hallmarks of Cancer.\n64. **^** Schabath & Cote 2019, \"Introduction\".\n65. ^ ***a*** ***b*** Bade & Dela Cruz 2020, \"Tobacco Smoke Carcinogens\".\n66. **^** \"Tobacco and Cancer\". Centers for Disease Control and Prevention. 18 November 2021. Retrieved 29 December 2022.\n67. **^** Massion & Lehman 2022, \"DNA Damage Response\".\n68. **^** Bade & Dela Cruz 2020, \"Environmental Tobacco Smoke\".\n69. **^** Bracken-Clarke et al. 2021, Abstract – \"Conclusion\".\n\n</fragment>\n<fragment>\n\n| Lung cancer |\n| --- |\n| Other names | Lung carcinoma |\n| ![X-ray with an arrow pointing to a hazy circular mass in the chest](image) |\n| A chest X-ray showing a tumor in the lung (marked by arrow) |\n| Specialty | Oncology, pulmonology |\n| Symptoms | Coughing (including coughing up blood), shortness of breath, chest pain |\n| Usual onset | After age 40;[1] 70 years on average[2] |\n| Types | Small-cell lung carcinoma (SCLC), non-small-cell lung carcinoma (NSCLC) |\n| Risk factors | * Tobacco smoking\n* Asbestos\n* Radon\n* Other environmental mutagens\n |\n| Diagnostic method | Medical imaging, tissue biopsy |\n| Prevention | Avoid smoking and other environmental mutagens |\n| Treatment | Surgery, chemotherapy, radiotherapy, molecular therapies, immune checkpoint inhibitors |\n| Prognosis | Five-year survival rate: 10 to 20% (most countries)[3] |\n| Frequency | 2.2 million (2020)[3] |\n| Deaths | 1.8 million (2020)[3] |\n\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_o0VEXA8LDvE3bzVDW34YWIzd","tool_calls":null,"is_tool_call_error":false}}
{"type":"root_message","msg":{"role":"function","content":"<document>\n<title>Lung cancer</title>\n<fragment>\nWorldwide, lung cancer is the most diagnosed type of cancer, and the leading cause of cancer death.[94][95] In 2020, 2.2 million new cases were diagnosed, and 1.8 million people died from lung cancer, representing 18% of all cancer deaths.[3] Lung cancer deaths are expected to rise globally to nearly 3 million annual deaths by 2035, due to high rates of tobacco use and aging populations.[95] Lung cancer is rare in those younger than 40; after that, cancer rates increase with age, stabilizing around age 80.[1] The median age of a person diagnosed with lung cancer is 70; the median age of death is 72.[2]\n\n\n</fragment>\n<fragment>\n\nAround 19% of people diagnosed with lung cancer survive five years from diagnosis, though prognosis varies based on the stage of the disease at diagnosis and the type of lung cancer.[4] Prognosis is better for people with lung cancer diagnosed at an earlier stage; those diagnosed at the earliest TNM stage, IA1 (small tumor, no spread), have a two-year survival of 97% and five-year survival of 92%.[57] Those diagnosed at the most-advanced stage, IVB, have a two-year survival of 10% and a five-year survival of 0%.[57] Five-year survival is higher in women (22%) than men (16%).[4] Women tend to be diagnosed with less-advanced disease, and have better outcomes than men diagnosed at the same stage.[58] Average five-year survival also varies across the world, with particularly high five-year survival in Japan (33%), and five-year survival above 20% in 12 other countries: Mauritius, Canada, the US, China, South Korea, Taiwan, Israel, Latvia, Iceland, Sweden, Austria, and Switzerland.[59]\n\n\n</fragment>\n<fragment>\n\nLung cancer is the most diagnosed and deadliest cancer worldwide, with 2.2 million cases in 2020 resulting in 1.8 million deaths.[3] Lung cancer is rare in those younger than 40; the average age at diagnosis is 70 years, and the average age at death 72.[2] Incidence and outcomes vary widely across the world, depending on patterns of tobacco use. Prior to the advent of cigarette smoking in the 20th century, lung cancer was a rare disease. In the 1950s and 1960s, increasing evidence linked lung cancer and tobacco use, culminating in declarations by most large national health bodies discouraging tobacco use.\n\n\n\n\n## Signs and symptoms[edit]\n\n\n</fragment>\n<fragment>\n\nLung cancer incidence varies by geography and sex, with the highest rates in Micronesia, Polynesia, Europe, Asia, and North America; and lowest rates in Africa and Central America.[96] Globally, around 8% of men and 6% of women develop lung cancer in their lifetimes.[1] The ratio of lung cancer cases in men to women varies considerably by geography, from as high as nearly 12:1 in Belarus, to 1:1 in Brazil, likely due to differences in smoking patterns.[97]\n\n\n</fragment>\n<fragment>\n57. ^ ***a*** ***b*** ***c*** Goldstraw et al. 2016, \"Figure 2\".\n58. ^ ***a*** ***b*** Rivera, Mody & Weiner 2022, \"Prognostic and Predictive Factors in Lung Cancer\".\n59. **^** Allemani et al. 2018, \"Lung\".\n60. ^ ***a*** ***b*** Temel, Petrillo & Greer 2022, \"Coping with Prognostic Uncertainty\".\n61. **^** \"What Causes Lung Cancer\". American Cancer Society. 1 October 2019. Retrieved 31 January 2023.\n62. **^** \"What Causes Lung Cancer?\". American Lung Association. 17 November 2022. Retrieved 31 January 2023.\n63. **^** Massion & Lehman 2022, Table 73.1: Hallmarks of Cancer.\n64. **^** Schabath & Cote 2019, \"Introduction\".\n65. ^ ***a*** ***b*** Bade & Dela Cruz 2020, \"Tobacco Smoke Carcinogens\".\n66. **^** \"Tobacco and Cancer\". Centers for Disease Control and Prevention. 18 November 2021. Retrieved 29 December 2022.\n67. **^** Massion & Lehman 2022, \"DNA Damage Response\".\n68. **^** Bade & Dela Cruz 2020, \"Environmental Tobacco Smoke\".\n69. **^** Bracken-Clarke et al. 2021, Abstract – \"Conclusion\".\n\n</fragment>\n<fragment>\n\n| Lung cancer |\n| --- |\n| Other names | Lung carcinoma |\n| ![X-ray with an arrow pointing to a hazy circular mass in the chest](image) |\n| A chest X-ray showing a tumor in the lung (marked by arrow) |\n| Specialty | Oncology, pulmonology |\n| Symptoms | Coughing (including coughing up blood), shortness of breath, chest pain |\n| Usual onset | After age 40;[1] 70 years on average[2] |\n| Types | Small-cell lung carcinoma (SCLC), non-small-cell lung carcinoma (NSCLC) |\n| Risk factors | * Tobacco smoking\n* Asbestos\n* Radon\n* Other environmental mutagens\n |\n| Diagnostic method | Medical imaging, tissue biopsy |\n| Prevention | Avoid smoking and other environmental mutagens |\n| Treatment | Surgery, chemotherapy, radiotherapy, molecular therapies, immune checkpoint inhibitors |\n| Prognosis | Five-year survival rate: 10 to 20% (most countries)[3] |\n| Frequency | 2.2 million (2020)[3] |\n| Deaths | 1.8 million (2020)[3] |\n\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_o0VEXA8LDvE3bzVDW34YWIzd","tool_calls":null,"is_tool_call_error":false}}
{"type":"kani_message","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","msg":{"role":"function","content":"<document>\n<title>Colorectal cancer</title>\n<fragment>\n\nAs of 2012[update], it is the second most common cause of cancer in women (9.2% of diagnoses) and the third most common in men (10.0%)[14]: 16 with it being the fourth most common cause of cancer death after lung, stomach, and liver cancer.[186] It is more common in developed than developing countries.[187] Global incidence varies 10-fold, with highest rates in Australia, New Zealand, Europe and the US and lowest rates in Africa and South-Central Asia.[188]\n\n\n\n### United States[edit]\n\n\n</fragment>\n<fragment>\nIt predicted that, in 2023, an estimated 19,550 diagnoses and 3,750 deaths would be in people younger than 50.[190] Colorectal cancer also disproportionately affects the Black community, where the rates are the highest of any racial/ethnic group in the US. African Americans are about 20% more likely to get colorectal cancer and about 40% more likely to die from it than most other groups. Black Americans often experience greater obstacles to cancer prevention, detection, treatment, and survival, including systemic racial disparities that are complex and go beyond the obvious connection to cancer.\n\n\n\n### United Kingdom[edit]\n\n\nIn the UK about 41,000 people a year get colon cancer making it the fourth most common type.[191]\n\n\n\n### Australia[edit]\n\n\nOne in 19 men and one in 28 women in Australia will develop colorectal cancer before the age of 75; one in 10 men and one in 15 women will develop it by 85 years of age.[192]\n\n\n\n### Papua New Guinea[edit]\n\n\n</fragment>\n<fragment>\n5. ^ ***a*** ***b*** ***c*** ***d*** ***e*** ***f*** ***g*** \"Colon Cancer Treatment (PDQ®)\". *NCI*. May 12, 2014. Archived from the original on July 5, 2014. Retrieved June 29, 2014.\n6. ^ ***a*** ***b*** \"SEER Stat Fact Sheets: Colon and Rectum Cancer\". *NCI*. Archived from the original on June 24, 2014. Retrieved June 18, 2014.\n7. **^** Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). \"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015\". *Lancet*. **388** (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.\n\n</fragment>\n<fragment>\n184. **^** McGeechan GJ, Byrnes K, Campbell M, Carthy N, Eberhardt J, Paton W, et al. (January 2021). \"A systematic review and qualitative synthesis of the experience of living with colorectal cancer as a chronic illness\". *Psychology & Health*. **37** (3): 350–374. doi:10.1080/08870446.2020.1867137. PMID 33499649. S2CID 231771176.\n185. **^** Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (December 2012). \"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010\". *Lancet*. **380** (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. hdl:10536/DRO/DU:30050819. PMID 23245604. S2CID 1541253.\n186. **^** WHO (February 2010). \"Cancer\". World Health Organization. Archived from the original on December 29, 2010. Retrieved January 5, 2011.\n\n</fragment>\n<fragment>\n\nTreatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy, and targeted therapy.[5] Cancers that are confined within the wall of the colon may be curable with surgery, while cancer that has spread widely is usually not curable, with management being directed towards improving quality of life and symptoms.[5] The five-year survival rate in the United States was around 65% in 2014.[6] The individual likelihood of survival depends on how advanced the cancer is, whether or not all the cancer can be removed with surgery, and the person's overall health.[1] Globally, colorectal cancer is the third most common type of cancer, making up about 10% of all cases.[14] In 2018, there were 1.09 million new cases and 551,000 deaths from the disease.[8] It is more common in developed countries, where more than 65% of cases are found.[2] It is less common in women than men.[2]\n\n\n\n\n## Signs and symptoms[edit]\n\n\n</fragment>\n<fragment>\nThe average five-year recurrence rate in people where surgery is successful is 5% for stage I cancers, 12% in stage II and 33% in stage III. However, depending on the number of risk factors it ranges from 9–22% in stage II and 17–44% in stage III.[173]\n\n\n\n### Survival rates[edit]\n\n\nIn Europe the five-year survival rate for colorectal cancer is less than 60%. In the developed world about a third of people who get the disease die from it.[20]\n\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_Nt6crxtybqLnYF5GFQMKVZC4","tool_calls":null,"is_tool_call_error":false}}
{"type":"root_message","msg":{"role":"function","content":"<document>\n<title>Colorectal cancer</title>\n<fragment>\n\nAs of 2012[update], it is the second most common cause of cancer in women (9.2% of diagnoses) and the third most common in men (10.0%)[14]: 16 with it being the fourth most common cause of cancer death after lung, stomach, and liver cancer.[186] It is more common in developed than developing countries.[187] Global incidence varies 10-fold, with highest rates in Australia, New Zealand, Europe and the US and lowest rates in Africa and South-Central Asia.[188]\n\n\n\n### United States[edit]\n\n\n</fragment>\n<fragment>\nIt predicted that, in 2023, an estimated 19,550 diagnoses and 3,750 deaths would be in people younger than 50.[190] Colorectal cancer also disproportionately affects the Black community, where the rates are the highest of any racial/ethnic group in the US. African Americans are about 20% more likely to get colorectal cancer and about 40% more likely to die from it than most other groups. Black Americans often experience greater obstacles to cancer prevention, detection, treatment, and survival, including systemic racial disparities that are complex and go beyond the obvious connection to cancer.\n\n\n\n### United Kingdom[edit]\n\n\nIn the UK about 41,000 people a year get colon cancer making it the fourth most common type.[191]\n\n\n\n### Australia[edit]\n\n\nOne in 19 men and one in 28 women in Australia will develop colorectal cancer before the age of 75; one in 10 men and one in 15 women will develop it by 85 years of age.[192]\n\n\n\n### Papua New Guinea[edit]\n\n\n</fragment>\n<fragment>\n5. ^ ***a*** ***b*** ***c*** ***d*** ***e*** ***f*** ***g*** \"Colon Cancer Treatment (PDQ®)\". *NCI*. May 12, 2014. Archived from the original on July 5, 2014. Retrieved June 29, 2014.\n6. ^ ***a*** ***b*** \"SEER Stat Fact Sheets: Colon and Rectum Cancer\". *NCI*. Archived from the original on June 24, 2014. Retrieved June 18, 2014.\n7. **^** Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). \"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015\". *Lancet*. **388** (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.\n\n</fragment>\n<fragment>\n184. **^** McGeechan GJ, Byrnes K, Campbell M, Carthy N, Eberhardt J, Paton W, et al. (January 2021). \"A systematic review and qualitative synthesis of the experience of living with colorectal cancer as a chronic illness\". *Psychology & Health*. **37** (3): 350–374. doi:10.1080/08870446.2020.1867137. PMID 33499649. S2CID 231771176.\n185. **^** Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (December 2012). \"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010\". *Lancet*. **380** (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. hdl:10536/DRO/DU:30050819. PMID 23245604. S2CID 1541253.\n186. **^** WHO (February 2010). \"Cancer\". World Health Organization. Archived from the original on December 29, 2010. Retrieved January 5, 2011.\n\n</fragment>\n<fragment>\n\nTreatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy, and targeted therapy.[5] Cancers that are confined within the wall of the colon may be curable with surgery, while cancer that has spread widely is usually not curable, with management being directed towards improving quality of life and symptoms.[5] The five-year survival rate in the United States was around 65% in 2014.[6] The individual likelihood of survival depends on how advanced the cancer is, whether or not all the cancer can be removed with surgery, and the person's overall health.[1] Globally, colorectal cancer is the third most common type of cancer, making up about 10% of all cases.[14] In 2018, there were 1.09 million new cases and 551,000 deaths from the disease.[8] It is more common in developed countries, where more than 65% of cases are found.[2] It is less common in women than men.[2]\n\n\n\n\n## Signs and symptoms[edit]\n\n\n</fragment>\n<fragment>\nThe average five-year recurrence rate in people where surgery is successful is 5% for stage I cancers, 12% in stage II and 33% in stage III. However, depending on the number of risk factors it ranges from 9–22% in stage II and 17–44% in stage III.[173]\n\n\n\n### Survival rates[edit]\n\n\nIn Europe the five-year survival rate for colorectal cancer is less than 60%. In the developed world about a third of people who get the disease die from it.[20]\n\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_Nt6crxtybqLnYF5GFQMKVZC4","tool_calls":null,"is_tool_call_error":false}}
{"type":"kani_message","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","msg":{"role":"function","content":"<document>\n<title>Cervical cancer</title>\n<fragment>\nWorldwide, cervical cancer is both the fourth-most common type of cancer and the fourth-most common cause of death from cancer in women.[3] In 2012, an estimated 528,000 cases of cervical cancer occurred, with 266,000 deaths.[3] This is about 8% of the total cases and total deaths from cancer.[21] About 70% of cervical cancers and 90% of deaths occur in developing countries.[3][22] In low-income countries, it is one of the most common causes of cancer death with an incidence rate of 47.3 per 100,000 women.[23][19] In developed countries, the widespread use of cervical screening programs has dramatically reduced rates of cervical cancer.[24] Expected scenarios for the reduction of mortality due to cervical cancer worldwide (and specially in low-income countries) have been reviewed, given assumptions with respect to the achievement of recommended prevention targets using triple-intervention strategies defined by WHO.[25] In medical research, the most famous immortalized cell line, known as HeLa, \n</fragment>\n<fragment>\n\n![](image)Age-standardized death from cervical cancer per 100,000 inhabitants in 2004[120] |  |  |\n| --- | --- |\n| no data\n <2.4\n 2.4–4.8\n 4.8–7.2\n 7.2–9.6\n 9.6–12\n 12–14.4\n | 14.4–16.8\n 16.8–19.2\n 19.2–21.6\n 21.6–24\n 24–26.4\n >26.4\n |\n\nWorldwide, cervical cancer is both the fourth-most common cause of cancer and deaths from cancer in women.[3] In 2018, 570,000 cases of cervical cancer were estimated to have occurred, with over 300,000 deaths.[121] It is the second-most common cause of female-specific cancer after breast cancer, accounting for around 8% of both total cancer cases and total cancer deaths in women.[21] About 80% of cervical cancers occur in developing countries.[122] It is the most frequently detected cancer during pregnancy, with an occurrence of 1.5 to 12 for every 100,000 pregnancies.[123]\n\n\n\n### Australia[edit]\n\n\n\n\n</fragment>\n<fragment>\n\nAs of 2022, the World Health Organization announced that \"each year in the WHO European Region more than 66 000 women are newly diagnosed with cervical cancer and more than 30 000 die from this preventable disease.\"[132]\n\n\n\n### United Kingdom[edit]\n\n\n\n\n|  |  |\n| --- | --- |\n| ![](image)\n | This section needs to be **updated**. Please help update this article to reflect recent events or newly available information. *(September 2021)*\n |\n\n\nCervical cancer is the 12th-most common cancer in women in the UK (around 3,100 women were diagnosed with the disease in 2011), and accounts for 1% of cancer deaths (around 920 died in 2012).[133] With a 42% reduction from 1988 to 1997, the NHS-implemented screening programme has been highly successful, screening the highest-risk age group (25–49 years) every 3 years, and those ages 50–64 every 5 years.[*citation needed*]\n\n\n\n### United States[edit]\n\n\n\n\n</fragment>\n<fragment>\n11. ^ ***a*** ***b*** Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (May 2021). \"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries\". *CA: A Cancer Journal for Clinicians*. **71** (3): 209–249. doi:10.3322/caac.21660. PMID 33538338. S2CID 231804598.\n12. **^** \"Defining Cancer\". *National Cancer Institute*. 17 September 2007. Archived from the original on 25 June 2014. Retrieved 10 June 2014.\n13. **^** Tarney CM, Han J (2014). \"Postcoital bleeding: a review on etiology, diagnosis, and management\". *Obstetrics and Gynecology International*. **2014**: 192087. doi:10.1155/2014/192087. PMC 4086375. PMID 25045355.\n14. **^** Dunne EF, Park IU (December 2013). \"HPV and HPV-associated diseases\". *Infectious Disease Clinics of North America*. **27** (4): 765–778. doi:10.1016/j.idc.2013.09.001. PMID 24275269.\n15. **^** \"Cervical cancer\". *www.who.int*. Retrieved 13 May 2022.\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_UjaSW8C5KZwdJYcOCW0gReqs","tool_calls":null,"is_tool_call_error":false}}
{"type":"root_message","msg":{"role":"function","content":"<document>\n<title>Cervical cancer</title>\n<fragment>\nWorldwide, cervical cancer is both the fourth-most common type of cancer and the fourth-most common cause of death from cancer in women.[3] In 2012, an estimated 528,000 cases of cervical cancer occurred, with 266,000 deaths.[3] This is about 8% of the total cases and total deaths from cancer.[21] About 70% of cervical cancers and 90% of deaths occur in developing countries.[3][22] In low-income countries, it is one of the most common causes of cancer death with an incidence rate of 47.3 per 100,000 women.[23][19] In developed countries, the widespread use of cervical screening programs has dramatically reduced rates of cervical cancer.[24] Expected scenarios for the reduction of mortality due to cervical cancer worldwide (and specially in low-income countries) have been reviewed, given assumptions with respect to the achievement of recommended prevention targets using triple-intervention strategies defined by WHO.[25] In medical research, the most famous immortalized cell line, known as HeLa, \n</fragment>\n<fragment>\n\n![](image)Age-standardized death from cervical cancer per 100,000 inhabitants in 2004[120] |  |  |\n| --- | --- |\n| no data\n <2.4\n 2.4–4.8\n 4.8–7.2\n 7.2–9.6\n 9.6–12\n 12–14.4\n | 14.4–16.8\n 16.8–19.2\n 19.2–21.6\n 21.6–24\n 24–26.4\n >26.4\n |\n\nWorldwide, cervical cancer is both the fourth-most common cause of cancer and deaths from cancer in women.[3] In 2018, 570,000 cases of cervical cancer were estimated to have occurred, with over 300,000 deaths.[121] It is the second-most common cause of female-specific cancer after breast cancer, accounting for around 8% of both total cancer cases and total cancer deaths in women.[21] About 80% of cervical cancers occur in developing countries.[122] It is the most frequently detected cancer during pregnancy, with an occurrence of 1.5 to 12 for every 100,000 pregnancies.[123]\n\n\n\n### Australia[edit]\n\n\n\n\n</fragment>\n<fragment>\n\nAs of 2022, the World Health Organization announced that \"each year in the WHO European Region more than 66 000 women are newly diagnosed with cervical cancer and more than 30 000 die from this preventable disease.\"[132]\n\n\n\n### United Kingdom[edit]\n\n\n\n\n|  |  |\n| --- | --- |\n| ![](image)\n | This section needs to be **updated**. Please help update this article to reflect recent events or newly available information. *(September 2021)*\n |\n\n\nCervical cancer is the 12th-most common cancer in women in the UK (around 3,100 women were diagnosed with the disease in 2011), and accounts for 1% of cancer deaths (around 920 died in 2012).[133] With a 42% reduction from 1988 to 1997, the NHS-implemented screening programme has been highly successful, screening the highest-risk age group (25–49 years) every 3 years, and those ages 50–64 every 5 years.[*citation needed*]\n\n\n\n### United States[edit]\n\n\n\n\n</fragment>\n<fragment>\n11. ^ ***a*** ***b*** Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (May 2021). \"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries\". *CA: A Cancer Journal for Clinicians*. **71** (3): 209–249. doi:10.3322/caac.21660. PMID 33538338. S2CID 231804598.\n12. **^** \"Defining Cancer\". *National Cancer Institute*. 17 September 2007. Archived from the original on 25 June 2014. Retrieved 10 June 2014.\n13. **^** Tarney CM, Han J (2014). \"Postcoital bleeding: a review on etiology, diagnosis, and management\". *Obstetrics and Gynecology International*. **2014**: 192087. doi:10.1155/2014/192087. PMC 4086375. PMID 25045355.\n14. **^** Dunne EF, Park IU (December 2013). \"HPV and HPV-associated diseases\". *Infectious Disease Clinics of North America*. **27** (4): 765–778. doi:10.1016/j.idc.2013.09.001. PMID 24275269.\n15. **^** \"Cervical cancer\". *www.who.int*. Retrieved 13 May 2022.\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_UjaSW8C5KZwdJYcOCW0gReqs","tool_calls":null,"is_tool_call_error":false}}
{"type":"kani_message","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","msg":{"role":"function","content":"<document>\n<title>Stomach cancer</title>\n<fragment>\n\nGlobally, stomach cancer is the fifth-leading type of cancer and the third-leading cause of death from cancer, making up 7% of cases and 9% of deaths.[17] In 2018, it newly occurred in 1.03 million people and caused 783,000 deaths.[10] Before the 1930s, it was a leading cause of cancer deaths in the Western world, however rates have sharply declined among younger generations in the West, while they remain high for people living in East Asia.[18][19][20] The decline in the West is believed to be due to the decline of salted and pickled food consumption, as a result of the development of refrigeration as a method of preserving food.[21] Stomach cancer occurs most commonly in East Asia, followed by Eastern Europe.[2] It occurs twice as often in males as in females.[2]\n\n\n\n\n## Signs and symptoms[edit]\n\n\n</fragment>\n<fragment>\nIn 2018, stomach cancer was the fifth most frequently diagnosed cancer worldwide, representing 5.7% of all cancer cases, and the third leading cause of death from cancers, being responsible for 8.2% of all cancer deaths.[97] Among men, 683 754 cases were diagnosed, accounting for 7.2% of all cancer cases, and among women, stomach cancer was diagnosed in 349 947 cases, accounting for 4.1% of all cancer cases.[97]\n\n\nIn 2012, stomach cancer was the fifth most-common cancer with 952,000 cases diagnosed.[17] It is more common both in men and in developing countries.[98][99] In 2012, it represented 8.5% of cancer cases in men, making it the fourth-most common cancer in men.[100] Also in 2012, the number of deaths was 700,000, having decreased slightly from 774,000 in 1990, making it the third-leading cause of cancer-related death (after lung cancer and liver cancer).[101][102]\n\n\n</fragment>\n<fragment>\n9. **^** Vos, Theo; et al. (October 2016). \"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015\". *Lancet*. **388** (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.\n10. ^ ***a*** ***b*** Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (November 2018). \"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries\". *CA: A Cancer Journal for Clinicians*. **68** (6): 394–424. doi:10.3322/caac.21492. PMID 30207593. S2CID 52188256.\n11. **^** \"Stomach (Gastric) Cancer\". *NCI*. January 1980. Archived from the original on 4 July 2014. Retrieved 1 July 2014.\n12. **^** Ruddon RW (2007). *Cancer biology* (4th ed.). Oxford University Press. p. 223. ISBN 9780195175431. Archived from the original on 15 September 2015.\n\n</fragment>\n<fragment>\n101. **^** Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (December 2012). \"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010\". *Lancet*. **380** (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. hdl:10536/DRO/DU:30050819. PMID 23245604. S2CID 1541253.\n102. **^** \"PRESS RELEASE N° 224 Global battle against cancer won't be won with treatment alone: Effective prevention measures urgently needed to prevent cancer crisis\" (PDF). *World Health Organization*. 3 February 2014. Archived (PDF) from the original on 3 March 2014. Retrieved 14 March 2014.\n103. **^** Mauad EC, Nogueira JL, Souza JM, Wohnrath DR, Oliveira AT, Colli G, Colli AM (2000). \"Câncer gástrico em adultos jovens\" [Gastric Cancer in Young Adults]. *Rev. Bras. Cancerol*. **46** (3): 299–304. doi:10.32635/2176-9745.RBC.2000v46n3.2441. S2CID 179189212. Archived from the original on 3 July 2009.\n\n</fragment>\n<fragment>\n\nLess than 5% of stomach cancers occur in people under 40 years of age, with 81.1% of that 5% in the age-group of 30 to 39 and 18.9% in the age-group of 20 to 29.[103]\n\n\nIn 2014, stomach cancer resulted in 0.61% of deaths (13,303 cases) in the U.S.[104] In China, stomach cancer accounted for 3.56% of all deaths (324,439 cases).[105][*unreliable source?*] The highest rate of stomach cancer was in Mongolia, at 28 cases per 100,000 people.[106][*unreliable source?*]\n\n\nIn the United Kingdom, stomach cancer is the 15th-most common cancer (around 7,100 people were diagnosed with stomach cancer in 2011), and it is the 10th-most common cause of cancer-related deaths (around 4,800 people died in 2012).[107]\n\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_RX0JlYpuntex7seC1lL3SoLN","tool_calls":null,"is_tool_call_error":false}}
{"type":"root_message","msg":{"role":"function","content":"<document>\n<title>Stomach cancer</title>\n<fragment>\n\nGlobally, stomach cancer is the fifth-leading type of cancer and the third-leading cause of death from cancer, making up 7% of cases and 9% of deaths.[17] In 2018, it newly occurred in 1.03 million people and caused 783,000 deaths.[10] Before the 1930s, it was a leading cause of cancer deaths in the Western world, however rates have sharply declined among younger generations in the West, while they remain high for people living in East Asia.[18][19][20] The decline in the West is believed to be due to the decline of salted and pickled food consumption, as a result of the development of refrigeration as a method of preserving food.[21] Stomach cancer occurs most commonly in East Asia, followed by Eastern Europe.[2] It occurs twice as often in males as in females.[2]\n\n\n\n\n## Signs and symptoms[edit]\n\n\n</fragment>\n<fragment>\nIn 2018, stomach cancer was the fifth most frequently diagnosed cancer worldwide, representing 5.7% of all cancer cases, and the third leading cause of death from cancers, being responsible for 8.2% of all cancer deaths.[97] Among men, 683 754 cases were diagnosed, accounting for 7.2% of all cancer cases, and among women, stomach cancer was diagnosed in 349 947 cases, accounting for 4.1% of all cancer cases.[97]\n\n\nIn 2012, stomach cancer was the fifth most-common cancer with 952,000 cases diagnosed.[17] It is more common both in men and in developing countries.[98][99] In 2012, it represented 8.5% of cancer cases in men, making it the fourth-most common cancer in men.[100] Also in 2012, the number of deaths was 700,000, having decreased slightly from 774,000 in 1990, making it the third-leading cause of cancer-related death (after lung cancer and liver cancer).[101][102]\n\n\n</fragment>\n<fragment>\n9. **^** Vos, Theo; et al. (October 2016). \"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015\". *Lancet*. **388** (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.\n10. ^ ***a*** ***b*** Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (November 2018). \"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries\". *CA: A Cancer Journal for Clinicians*. **68** (6): 394–424. doi:10.3322/caac.21492. PMID 30207593. S2CID 52188256.\n11. **^** \"Stomach (Gastric) Cancer\". *NCI*. January 1980. Archived from the original on 4 July 2014. Retrieved 1 July 2014.\n12. **^** Ruddon RW (2007). *Cancer biology* (4th ed.). Oxford University Press. p. 223. ISBN 9780195175431. Archived from the original on 15 September 2015.\n\n</fragment>\n<fragment>\n101. **^** Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (December 2012). \"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010\". *Lancet*. **380** (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. hdl:10536/DRO/DU:30050819. PMID 23245604. S2CID 1541253.\n102. **^** \"PRESS RELEASE N° 224 Global battle against cancer won't be won with treatment alone: Effective prevention measures urgently needed to prevent cancer crisis\" (PDF). *World Health Organization*. 3 February 2014. Archived (PDF) from the original on 3 March 2014. Retrieved 14 March 2014.\n103. **^** Mauad EC, Nogueira JL, Souza JM, Wohnrath DR, Oliveira AT, Colli G, Colli AM (2000). \"Câncer gástrico em adultos jovens\" [Gastric Cancer in Young Adults]. *Rev. Bras. Cancerol*. **46** (3): 299–304. doi:10.32635/2176-9745.RBC.2000v46n3.2441. S2CID 179189212. Archived from the original on 3 July 2009.\n\n</fragment>\n<fragment>\n\nLess than 5% of stomach cancers occur in people under 40 years of age, with 81.1% of that 5% in the age-group of 30 to 39 and 18.9% in the age-group of 20 to 29.[103]\n\n\nIn 2014, stomach cancer resulted in 0.61% of deaths (13,303 cases) in the U.S.[104] In China, stomach cancer accounted for 3.56% of all deaths (324,439 cases).[105][*unreliable source?*] The highest rate of stomach cancer was in Mongolia, at 28 cases per 100,000 people.[106][*unreliable source?*]\n\n\nIn the United Kingdom, stomach cancer is the 15th-most common cancer (around 7,100 people were diagnosed with stomach cancer in 2011), and it is the 10th-most common cause of cancer-related deaths (around 4,800 people died in 2012).[107]\n\n\n</fragment>\n</document>","name":"search","tool_call_id":"call_RX0JlYpuntex7seC1lL3SoLN","tool_calls":null,"is_tool_call_error":false}}
{"type":"kani_message","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","msg":{"role":"assistant","content":"Here are the symptoms of the top 5 mortality cancers in the world amongst females:\n\n1. **Breast Cancer**:\n   - A lump in a breast\n   - A change in breast shape\n   - Dimpling of the skin\n   - Fluid from the nipple\n   - A newly inverted nipple\n   - A red scaly patch of skin on the breast\n\n2. **Lung Cancer**:\n   - Coughing (including coughing up blood)\n   - Shortness of breath\n   - Chest pain\n\n3. **Colorectal Cancer**:\n   - Changes in bowel habits (e.g., diarrhea, constipation, or narrowing of the stool)\n   - Rectal bleeding or blood in the stool\n   - Persistent abdominal discomfort (e.g., cramps, gas, or pain)\n   - A feeling that the bowel does not empty completely\n   - Weakness or fatigue\n   - Unexplained weight loss\n\n4. **Cervical Cancer**:\n   - Vaginal bleeding after intercourse, between periods, or after menopause\n   - Watery, bloody vaginal discharge that may be heavy and have a foul odor\n   - Pelvic pain or pain during intercourse\n\n5. **Stomach Cancer**:\n   - Difficulty swallowing\n   - Feeling bloated after eating\n   - Feeling full after eating small amounts of food\n   - Heartburn\n   - Indigestion\n   - Nausea\n   - Stomach pain\n   - Unintentional weight loss\n   - Vomiting (which may include blood)\n\nThese symptoms can vary in severity and may overlap with other conditions, so it is important to consult a healthcare professional for an accurate diagnosis.","name":null,"tool_call_id":null,"tool_calls":null,"is_tool_call_error":null}}
{"type":"root_message","msg":{"role":"assistant","content":"Here are the symptoms of the top 5 mortality cancers in the world amongst females:\n\n1. **Breast Cancer**:\n   - A lump in a breast\n   - A change in breast shape\n   - Dimpling of the skin\n   - Fluid from the nipple\n   - A newly inverted nipple\n   - A red scaly patch of skin on the breast\n\n2. **Lung Cancer**:\n   - Coughing (including coughing up blood)\n   - Shortness of breath\n   - Chest pain\n\n3. **Colorectal Cancer**:\n   - Changes in bowel habits (e.g., diarrhea, constipation, or narrowing of the stool)\n   - Rectal bleeding or blood in the stool\n   - Persistent abdominal discomfort (e.g., cramps, gas, or pain)\n   - A feeling that the bowel does not empty completely\n   - Weakness or fatigue\n   - Unexplained weight loss\n\n4. **Cervical Cancer**:\n   - Vaginal bleeding after intercourse, between periods, or after menopause\n   - Watery, bloody vaginal discharge that may be heavy and have a foul odor\n   - Pelvic pain or pain during intercourse\n\n5. **Stomach Cancer**:\n   - Difficulty swallowing\n   - Feeling bloated after eating\n   - Feeling full after eating small amounts of food\n   - Heartburn\n   - Indigestion\n   - Nausea\n   - Stomach pain\n   - Unintentional weight loss\n   - Vomiting (which may include blood)\n\nThese symptoms can vary in severity and may overlap with other conditions, so it is important to consult a healthcare professional for an accurate diagnosis.","name":null,"tool_call_id":null,"tool_calls":null,"is_tool_call_error":null}}
{"type":"tokens_used","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","prompt_tokens":6877,"completion_tokens":349}
{"type":"kani_state_change","id":"c8ca27ca-3ec8-4387-be4c-2c05e37f97dc","state":"stopped"}
{"type":"round_complete","session_id":"1718430136-7acb6d0b-69b0-45e5-b296-4c9b43ae9e32"}
